OC
Oxbridge Clinical Inc.
SEC filingBiotechnology · Boston, MA
Amount raised$4.5Msold at filing
Total offering$4.5M
Investors in the raise3count reported to the SEC
FiledNov 3, 2025first sale Oct 8, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Guilio DeangeliExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.